Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension

被引:130
作者
Asico, LD
Ladines, C
Fuchs, S
Accili, D
Carey, RM
Semeraro, C
Pocchiari, F
Felder, RA
Eisner, GM
Jose, PA
机构
[1] Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA
[2] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA
[3] Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Washington, DC 20007 USA
[4] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[5] NICHHD, Dev Endocrinol Branch, Bethesda, MD 20892 USA
[6] Zambon Grp SpA, I-20091 Bresso, MI, Italy
[7] Univ Virginia, Hlth Sci Ctr, Dept Med, Charlottesville, VA 22908 USA
[8] Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA 22908 USA
关键词
dopamine receptor; D-3 receptor gene; renin; catecholamines;
D O I
10.1172/JCI3685
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Since dopamine receptors are important in the regulation of renal and cardiovascular function, we studied the cardiovascular consequences of the disruption of the D-3 receptor, a member of the family of D-2-like receptors, expressed in renal proximal tubules and juxtaglomerular cells. Systolic and diastolic blood pressures were higher (similar to 20 mmHg) in heterozygous and homozygous than in wild-type mice. An acute saline load increased urine flow rate and sodium excretion to a similar extent in wild-type and heterozygous mice but the increase was attenuated in homozygous mice. Renal renin activity was much greater in homozygous than in wild-type mice; values for heterozygous mice were intermediate, Blockade of angiotensin II subtype-1 receptors decreased systolic blood pressure for a longer duration in mutant than in wild-type mice. Thus, disruption of the D3 receptor increases renal renin production and produces renal sodium retention and renin-dependent hypertension.
引用
收藏
页码:493 / 498
页数:6
相关论文
共 39 条
[1]   A targeted mutation of the D-3 dopamine receptor gene is associated with hyperactivity in mice [J].
Accili, D ;
Fishburn, CS ;
Drago, J ;
Steiner, H ;
Lachowicz, JE ;
Park, BH ;
Gauda, EB ;
Lee, EJ ;
Cool, MH ;
Sibley, DR ;
Gerfen, CR ;
Westphal, H ;
Fuchs, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :1945-1949
[2]   Role of the D-1A dopamine receptor in the pathogenesis of genetic hypertension [J].
Albrecht, FE ;
Drago, J ;
Felder, RA ;
Printz, MP ;
Eisner, GM ;
Robillard, JE ;
Sibley, DR ;
Westphal, HJ ;
Jose, PA .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (10) :2283-2288
[3]   EVIDENCE THAT SPECIFIC DOPAMINE-1 RECEPTOR ACTIVATION IS INVOLVED IN DOPAMINE-INDUCED RENIN RELEASE [J].
ANTONIPILLAI, I ;
BROERS, MI ;
LANG, D .
HYPERTENSION, 1989, 13 (05) :463-468
[4]   DOPAMINE-RECEPTOR DISTRIBUTION IN THE RAT CNS - ELUCIDATION USING ANTIPEPTIDE ANTISERA DIRECTED AGAINST D-1A AND D-3 SUBTYPES [J].
ARIANO, MA ;
SIBLEY, DR .
BRAIN RESEARCH, 1994, 649 (1-2) :95-110
[5]   INHIBITION OF PROXIMAL TUBULE NA+-K+-ATPASE ACTIVITY REQUIRES SIMULTANEOUS ACTIVATION OF DA1 AND DA2 RECEPTORS [J].
BERTORELLO, A ;
APERIA, A .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (06) :F924-F928
[6]   Evaluation of the angiotensinogen locus in human essential hypertension - A European study [J].
Brand, E ;
Chatelain, N ;
Keavney, B ;
Caulfield, M ;
Citterio, L ;
Connell, J ;
Grobbee, D ;
Schmidt, S ;
Schunkert, H ;
Schuster, H ;
Sharma, AM ;
Soubrier, F .
HYPERTENSION, 1998, 31 (03) :725-729
[7]   DOPAMINE FAILS TO INHIBIT RENAL TUBULAR SODIUM-PUMP IN HYPERTENSIVE RATS [J].
CHEN, CJ ;
BEACH, RE ;
LOKHANDWALA, MF .
HYPERTENSION, 1993, 21 (03) :364-372
[8]  
FERGUSON M, 1991, RENAL PHYSIOL BIOCH, V14, P55
[9]   Blunted renal vascular response to angiotensin II is associated with a common Variant of the angiotensinogen gene and obesity [J].
Hopkins, PN ;
Lifton, RP ;
Hollenberg, NK ;
Jeunemaitre, X ;
Hallouin, MC ;
Skuppin, J ;
Williams, CS ;
Dluhy, RG ;
Lalouel, JM ;
Williams, RR ;
Williams, GH .
JOURNAL OF HYPERTENSION, 1996, 14 (02) :199-207
[10]   THE EFFECT OF CARBIDOPA AND INDOMETHACIN ON THE RENAL RESPONSE TO GAMMA-L-GLUTAMYL-L-DOPA IN NORMAL MAN [J].
JEFFREY, RF ;
MACDONALD, TM ;
MARWICK, K ;
LEE, MR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (02) :195-201